Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insmed Inc INSM

Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs... see more

Recent & Breaking News (NDAQ:INSM)

Watch These 5 Huge Put Purchases In Tuesday Trade

Benzinga.com  February 7, 2017

Lifshitz & Miller Law Firm Announces Investigation of Calamos Asset Management, Inc., CDI Corp., comScore, Inc., Earthstone Energy, Inc., Heritage Oaks Bancorp, Insmed Incorporated, OCI Partners LP and Vascular Solutions, Inc.

PR Newswire January 17, 2017

Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 4, 2017

Insmed to Participate at November Investor Conferences

GlobeNewswire November 14, 2016

Robbins Arroyo LLP Is Investigating the Officers and Directors of Insmed, Inc. (INSM) on Behalf of Shareholders

Business Wire November 4, 2016

Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update

GlobeNewswire November 3, 2016

Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016

GlobeNewswire October 27, 2016

Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease

GlobeNewswire October 18, 2016

Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor

GlobeNewswire October 5, 2016

Insmed Appoints Roger Adsett as Chief Commercial Officer

GlobeNewswire September 27, 2016

DEADLINE TOMORROW: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016 - INSM

GlobeNewswire September 12, 2016

Insmed to Participate at September Investor Conferences

GlobeNewswire September 8, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016 – INSM

GlobeNewswire September 7, 2016

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016

GlobeNewswire September 2, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016

Business Wire September 2, 2016

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Insmed Incorporated Of Upcoming Deadline

GlobeNewswire September 1, 2016

Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress

GlobeNewswire August 31, 2016

INSM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016

Business Wire August 29, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline – INSM

GlobeNewswire August 28, 2016

INSM INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016

PR Newswire August 24, 2016
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse